FinnCap reissued their corporate rating on shares of Omega Diagnostics Group (LON:ODX) in a research report report published on Monday, ThisIsMoney.Co.Uk reports.
The firm has a market capitalization of $11.33 million and a P/E ratio of -1.63. The firm’s 50-day simple moving average is GBX 9.78 and its two-hundred day simple moving average is GBX 11.37. Omega Diagnostics Group has a 1 year low of GBX 8.25 ($0.11) and a 1 year high of GBX 18 ($0.24). The company has a quick ratio of 1.18, a current ratio of 1.82 and a debt-to-equity ratio of 3.80.
Omega Diagnostics Group Company Profile
Omega Diagnostics Group PLC, through its subsidiaries, develops, manufactures, and distributes medical diagnostics products. The company operates in three segments: Allergy and Autoimmune, Food Intolerance, and Infectious Diseases and Other. The Allergy and Autoimmune segment engages in the research, development, production, and marketing of in-vitro allergy and autoimmune tests used by doctors to diagnose patients with allergies and autoimmune diseases.
Recommended Story: How Important is Technical Analysis of Stocks
Receive News & Ratings for Omega Diagnostics Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Diagnostics Group and related companies with MarketBeat.com's FREE daily email newsletter.